Stock listing

Genmab A/s

Selected listing: GE91 · MUN · EUR · DE

Genmab A/s (Munich:GE91), Health Technology. Latest release Oct 3, 2026: Genmab A/S : Announces Rinatabart Sesutecan (Rina-S) Phase 2 RAINFOLTM-01 Results…

GE91:MUNEURDEUpdated October 2, 2026

Ticker: Munich:GE91
Asset type: Stock
Sector: Health Technology
Industry: Biotechnology
Exchange: Munich
Currency: EUR

Latest news from Genmab A/s

Genmab A/S : Announces Rinatabart Sesutecan (Rina-S) Phase 2 RAINFOLTM-01 Results Demonstrated Durable and Clinically Meaningful Responses in Patients with Platinum-Resistant Ovarian Cancer

October 3, 2026

Genmab Announces Rinatabart Sesutecan (Rina-S®) Phase 2 RAINFOL™-01 Results Demonstrated Durable and Clinically Meaningful Responses in Patients with Platinum-Resistant Ovarian Cancer

October 3, 2026

Notice to Convene an Extraordinary General Meeting of Genmab A/S

September 8, 2026

Genmab A/S : Interim Report for the First Half of 2026

August 6, 2026

Genmab Announces Financial Results for the First Half of 2026

August 6, 2026

All Genmab A/s news →

Events

Replays

Genmab A/S (GMAB) Q2 2026 Earnings Call
Thu, Aug 06, 2026 · 12:00 PM ET
Watch
Genmab A/S (GMAB) Q1 2026 Earnings Call
Thu, May 07, 2026 · 12:00 PM ET
Watch
Genmab A/S (GMAB) Q4 2025 Earnings Call
Tue, Feb 17, 2026 · 12:00 PM ET
Watch

Research Genmab A/s

Genmab A/s company profile

View the public company page for Genmab A/s on 6ix.

Genmab A/s news

Read company news and market updates connected to Genmab A/s.

Genmab A/s investor events

Find investor webinars, events, and replay context for Genmab A/s.